The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I`m just curious, but what has happened to Riddler these days?
Hi Kidlington, This was announced a month or so after the interims RNS and part of the stated pipeline but I don't think Servier is that large? Possibly that one still to come?
Hi ooofffttt, Didn't mean to insult you but I genuinely hadn't realised that you were referring to the interim statement. That was only some 3.5 months ago and the Servier contract was already announced. My take on that was that although they were described as discussions that were advanced experience shows that time is still needed - particularly with the larger companies we are now dealing with.
I would think this stock is far too small and illiquid for anyone to seriously short. More likely lack of interest.
I am now of the opinion that the "large pharmaceutical client" alluded to is in fact the RNS about Servier. Thou in the RNS is does not state "large pharma" it says "international pharma", I was expecting that if a new client had been signed up, then a RNS would say something along the lines of "This is the large pharma we alluded to in the interim's?"
Maybe JM is just playing with words?
Anyway down again. Is someone shorting this? The SP now has to double to get back to where we were a some months ago.
Truro, from the interims: "In addition, the Company has a strong pipeline of projects in advanced discussion, including one with a potential new large pharmaceutical client."
This "potential new large pharmaceutical client." has been brought up here many times, yet failed to materialise.
"Either the pipeline was not as attractive (or as advanced) as suggested or is the BDM failing to deliver? " is a valid question which can't be dismissed in the insulting way you've done to the poster that posed it.
1) You called what was announced as contracts a pipeline. You can't turn existing contracts into contract/sales as they're already a fact!
2) This is a personal decision and I would be surprised at any comment.
However if you truly want a response from JM then this is not the place to pose those questions. As regards the low SP, I have 6 companies on AIM 1 of which is suspended and the remaining 5 are all in the same boat as PYC in that they are looking to breakeven/break into profit. All are at their lowest SP for 12 months or over - it's just the way it is. Markets are down.
So all the gains made on Monday, wiped off and more in last few days.
no 30k seller today, maybe they have transitioned into selling 100k chunks?
Just as soon as i think the SP cant go lower, down it goes.
I guess if anyone is thinking of buying here, they balk at the thought, see if the SP stabilises?
Perhaps email him as I would assume he wouldn't be likely to read a discussion forum?
Some very good points made there
If nothing else, as sure as the sun comes up in the morning, the seller has returned.
Dr Jim Millen – if you read these boards a couple of really simple questions I was hoping you could answer:
1) You stated in March the current pipeline is the best it has ever been (and a new Head of Business Development was appointed in August last year) There are also a number of projects in advanced discussions. Why is this not transitioning into more contracts/sales? Either the pipeline was not as attractive (or as advanced) as suggested or is the BDM failing to deliver? How do you plan to address this?
2) The share prices again is now sitting at a new 12 month low.
If the company is in as good a position as ever (best ever according to you in March) then why have none of the Directors purchased shares?
Yours - a really ****ed off share holder!!
Ok, not yesterday, more like Late May, however, PYC only tweeted about it yesterday.
Fantastic. I ought to go to Hospital for check up and tests more often!
Went to Hospital for checks after February head trauma etc. All good. Came back and saw we are up near 10%, the optimism dampened a tad by the 30k pesky seller who is still about.
Good to see JM at the opening of the new Bicycle Therapeutics site in Cambridge yesterday. https://twitter.com/Physiomics/status/1538860068371931137?s=20&t=4ZuAuZqY6WFl0hrupuOIZA
Indeedy Yes, 12 months ago our SP was double at 6/7P. PYC is in a far better place now. Small trades have been a feature and previous posters, over some years, have commented on low 'floating shares' situation with share shortage skewing things. Not that I understand this shortage?
However the sheer number of both small and large successful companies that we are linked with is proof of our Virtual Tumor offering and the subsequent new business collaborations. Never mind the SP - this company is about to strongly increase revenue with little extra cost to the bottom line. Oh happy days!!
Hi Pedro
There was a £5k today and £6k Friday
Atb
nice but its very low volume and small £1K and less trades
Nice to see some buys
Balanced replies in fairness from you all . Thanks. I did sell some of my holding on Friday but retain a reasonable amount in case pyc do come good which I hope it does. Gonna buy in different sectors. I'm fed up of waiting with the likes of val and sar and in fact pyc too. So at least now I won't get wound up with non action. Sold half of sar and val holdings too at least I've slept better best wishes to all her that pyc come good
Just a little but harsh! PYC is a very tight knit operation. Last years accounts show only 7 employees. I think we are now at 9. Because of this the BoD is very much hands on and alive to PYC's real situation. The latest NED was in fact an advisor anyway. Because we are extremely specialised we have a very targeted approach. This can be a danger of course but Cancer research is now getting massive attention and PYC is ideally poised to benefit. Wait for the June accounts and perhaps re-think your opinion?
Outlook
The Directors believe the Company is in a very strong position to meet market expectations for this year as it continues to make good progress in each of its key business areas.
The year end is June 30th,and as far as I can see they have delivered what they said they would over the last 9mths and on course for record figures
The share prices of most companies over the last 4mths do not reflect the progress made, and for example PYC had a large buy on Friday at full price of 3.9p and yet the market makers did not reflect that In the share price
When I checked late Friday there was about 75,000 shares available..
Sienna you have £100 worth of shares.
Stop panicking you either loss 100 quid or gain Hundreds.
Not much risk Vs reward.
So chill.
You are staying this about the BOD - have you ever contacted them? Asked questions and have open dialogue? No thought not.
I can see that you feel that way about most of your shares on Friday ( SAR VAL ARCL etc)
This appears to be a very tough market which is why I'm positioned in Hugh yield or non discretionary companies in medicine tech
Oncology spending will continue throughout this difficult economy and I believe SCLP and PYC will continue to attract investment
JOKE!!!!!
Truro, last year you had a feeling it would be a milestone year for PYC. The share price now languishes sub 4p, why are you still predicting things and talking about your feelings?
Yep, some womble paid of just over 250k this morning, way above the offer price at the time, only to sell out a few hours later. Give your head a wobble!! At least another 250k buy went thru shortly after.
All this for a 4mcap coy.
Last June year end was preceded by an April update that sugared the pill a little. Although sales were not as expected because of Covid drag other positive measures were announced. This year will be different as my guess is that record revenues will get us close to breakeven if not in profits. However my interest will be on the progress of the various business streams. If these are positive then I feel that we may well see an SP increase to reflect this and 6/7p may well be achievable because although our basic running costs will have risen because of head count increases our other costs are pretty stable. Hopefully get an update in some 6 weeks or so?
Got a good feeling about this company - it's in the right oncology sector at a time when personalised medical drugs are being researched in a wide and growing area. Onwards and upwards folks!